潜在抗冠状病毒药物瑞德西韦研究进展  

Research progress of potential anti-coronavirus drug remdesivir

作　　者：乔欢[1] 孙超[2] QIAO Huan;SUN Chao(Department of Oncology,the Third People’s Hospital of Bengbu,Bengbu ANHUI 233099,China;Department of Pharmacy,the Third People’s Hospital of Bengbu,Bengbu ANHUI 233099,China)

机构地区：[1]蚌埠市第三人民医院肿瘤内科,安徽蚌埠233099 [2]蚌埠市第三人民医院药学部,安徽蚌埠233099

出　　处：《中国新药与临床杂志》2020年第3期141-145,共5页Chinese Journal of New Drugs and Clinical Remedies

摘　　要：冠状病毒(CoV)是一种正向单链RNA病毒,可以广泛感染人类及其他脊椎动物,部分人畜共患的病毒变异体对人类社会造成了较大影响。瑞德西韦是一种核苷类似物,在细胞及动物实验中表现出了一定的广谱抗病毒作用,具有作为广谱抗CoV药物的潜力。Coronavirus(CoV) is a forward single-stranded RNA virus that can widely infect humans and other vertebrates. Some zoonotic virus variants have affected human society to some extent. Remdesivir is a nucleoside analog that shows a certain broad-spectrum antiviral effect in cell and animal experiments, and has the potential as a broad-spectrum anti-CoV drug.

关 键 词：冠状病毒感染 瑞德西韦 新型冠状病毒肺炎 SARS-CoV-2 

分 类 号：R978.7[医药卫生—药品]